IMP A SDB — Implantica AG Share Price
0.000.00%
Last trade - 00:00- SEK33.13bn
- SEK32.40bn
- €1.94m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 29.37 | ||
| Price to Tang. Book | 44.73 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1,558.42 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -25.27% | ||
| Return on Equity | -20.29% | ||
| Operating Margin | -1315.39% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 0.15 | 0.39 | 0.84 | 1.41 | 1.94 | 5.96 | 24.83 | 133.32% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Implantica AG is Lichtenstein-based medical technology Company, whose mission is to provide effective treatment for serious health conditions and to improve patients' life through the use of advanced technologies in the human body, ultimately aiming to reduce costs and increase efficiency in the healthcare System. The therapies developed by Implantica are based on implants that are inserted into the patient's body and remain in the body permanently or semi-permanently to replace bodily functions and/or treat diseases. The Company focuses on the discovery, development and prospective commercialization of medical products and implants that are intended for use in different treatment fields like in the area of gastrointestinal surgery and urology. The Company's lead product is RefluxStop, a passive, implant to prevent gastroesophageal reflux disease (GERD).
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- February 7th, 2020
- Public Since
- September 21st, 2020
- No. of Employees
- 50
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 1,183,211,537
- Address
- Landstrasse 1, VADUZ, 9490
- Web
- https://www.implantica.com/
- Phone
- Auditors
- KPMG AG
Upcoming Events for IMP A SDB
Implantica AG Annual Shareholders Meeting
Q2 2025 Implantica AG Earnings Release
Similar to IMP A SDB
Acarix AB
OMX Nordic Exchange Stockholm
AddLife AB
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
Arcoma AB
OMX Nordic Exchange Stockholm
FAQ
What is the Implantica AG share price?
As of Today at 21:15 UTC, shares in Implantica AG are trading at SEK28.00. This share price information is delayed by 15 minutes.
How has the Implantica AG share price performed this year?
Shares in Implantica AG last closed at SEK28.00 and the price had moved by +2% over the past 365 days. In terms of relative price strength the Implantica AG share price has underperformed the FTSE Global All Cap Index by -0.55% over the past year.
What are the analyst and broker recommendations for Implantica AG?
The overall consensus recommendation for Implantica AG is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Implantica AG dividend yield?
Implantica AG does not currently pay a dividend.
Does Implantica AG pay a dividend?
Implantica AG does not currently pay a dividend.
When does Implantica AG next pay dividends?
Implantica AG does not currently pay a dividend.
How do I buy Implantica AG shares?
To buy shares in Implantica AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Implantica AG?
As of the previous close price of SEK28.00, shares in Implantica AG had a market capitalisation of SEK33.13bn.
Where are Implantica AG shares listed?
Here are the trading details for Implantica AG:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: IMP A SDB
What kind of share is Implantica AG?
Based on an overall assessment of its quality, value and momentum Implantica AG is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Implantica AG share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Implantica AG share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Implantica AG. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -34.13%.
As of the last closing price of SEK28.00, shares in Implantica AG were trading -26% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Implantica AG PE Ratio?
The Implantica AG PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK28.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Implantica AG?
We do not have data on Implantica AG's directors